American College of Cardiology and the Cardiovascular Research Foundation Announce Formal Education Collaboration
Contact: Amy Murphy, firstname.lastname@example.org, 202-375-6476
ACC to Become Co-Sponsor of TCT in 2011
WASHINGTON, DC – SEPTEMBER 23, 2010 – The Cardiovascular Research Foundation (CRF) and the American College of Cardiology (ACC) jointly announced today an educational collaboration that formalizes and expands the existing relationship between the two organizations.
Beginning in 2011, ACC will become an official co-sponsor of Transcatheter Cardiovascular Therapeutics (TCT), the annual medical and scientific symposium of CRF, which will become known as “Transcatheter Cardiovascular Therapeutics (TCT) In Partnership with ACC.” CRF and ACC have had an existing partnership agreement since 2008, whereby CRF helps coordinate the interventional content at the Innovations in Interventions (i2) Summit at ACC’s Annual Scientific Sessions meeting. The enhanced partnership will involve sharing of content and distribution of educational materials. In addition, co-sponsorship of Continuing Medical Education (CME) awarded for meeting attendance and participation will be explored.
The two organizations will form a physician-led “Collaborative Council” comprised of senior physician leaders from both organizations. The Council will meet regularly to review progress towards established objectives and to set the strategic direction of the affiliation. Further national and international educational program collaborations and scientific efforts will be explored jointly. ACC and CRF staff will also meet regularly to share best practices, consider joint procurement of vendors to provide services and products on behalf of the collaboration, consider reciprocal exposition space at annual meetings, and explore collaboration around industry training programs.
“We believe the entire cardiology community – interventionalists, surgeons, clinicians, researchers, nurses and technicians – will benefit by an enhanced level of cooperation between the ACC and CRF,” said Gregg W. Stone, MD, Professor of Medicine at Columbia University College of Physicians and Surgeons, Director of Cardiovascular Research and Education at the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital/Columbia University Medical Center and Co-Director of the Medical Research and Education Division at the Cardiovascular Research Foundation. “It is our hope that providing leading edge medical education on a year-round basis will help appropriately translate evidence-based science into clinical practice.”
“CRF’s prior partnership in the i2 Summit, held in conjunction with the ACC Annual Scientific Session, demonstrated there is a growing universality and need for educational collaboration,” said David Holmes, M.D., president-elect of the ACC.
The American College of Cardiology is transforming cardiovascular care and improving heart health through continuous quality improvement, patient-centered care, payment innovation and professionalism. The College is a 39,000-member nonprofit medical society comprised of physicians, nurses, nurse practitioners, physician assistants, pharmacists and practice managers, and bestows credentials upon cardiovascular specialists who meet its stringent qualifications. The College is a leader in the formulation of health policy, standards and guidelines, and is a staunch supporter of cardiovascular research. The ACC provides professional education and operates national registries for the measurement and improvement of quality care. More information about the association is available online at http://www.cardiosource.org/ACC.
About CRF and TCT
The Cardiovascular Research Foundation (CRF) is an independent, academically focused nonprofit organization dedicated to improving the survival and quality of life for people with cardiovascular disease through research and education. Since its inception in 1991, CRF has played a major role in realizing dramatic improvements in the lives of countless numbers of patients by establishing the safe use of new technologies and therapies in interventional cardiovascular medicine.
Transcatheter Cardiovascular Therapeutics (TCT) is the annual scientific symposium of the Cardiovascular Research Foundation. TCT gathers leading medical researchers and clinicians from over 90 countries around the world to present and discuss the latest developments in the field.
For more information, visit www.crf.org.